Strategy& Insider Episode 9 - Revolutionizing diagnostics with digital biomarkers

Strategy& Insider

Content provided by Thomas Solbach, Ghioia Irritier, Jan-Philipp Loch, Thomas Solbach, Ghioia Irritier, and Jan-Philipp Loch. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Thomas Solbach, Ghioia Irritier, Jan-Philipp Loch, Thomas Solbach, Ghioia Irritier, and Jan-Philipp Loch or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

4y ago 46:53

MP3•Episode home

Archived series ("Inactive feed" status)

When? This feed was archived on September 29, 2021 21:10 (2+ y ago). Last successful fetch was on December 07, 2020 02:06 (3+ y ago)

Why? Inactive feed status. Our servers were unable to retrieve a valid podcast feed for a sustained period.

What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.

Conversation with Dan Vahdat The ninth episode brings you ever closer to the future of healthcare with Thomas discussing the possibilities of digital biomarkers for modern medicine with Dan Vahdat, founder and CEO of Huma (formerly: Medopad). Together, they shed light on the prospect of diagnosing diseases in the earliest stages and how this contributes to a more preventative and personalized care for patients.

14 episodes

#MBA #Fitness #Business #Medicine #Thomas Solbach, Ghioia Irritier, Jan-Philipp Loch #Ghioia Irritier #Jan-Philipp Loch #Thomas Solbach #Strategy #Advisory #Healtchcare #Biopharma #Pharma #Bioinformatics #Health and Well-Being #Future Health #Strategy Consulting